Advertisement
Screener

Klaviyo, Inc. (KVYO) Spending and interest coverage

Klaviyo, Inc. (KVYO) Spending and interest coverage

  • R&D / revenue · 12 months: Value 23.13%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 12.34%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months23.13%Research and development expense / revenue. Period ending 2026-06-30.

$321.37M ÷ $1.39B × 100 ≈ 23.13%

Stock-based compensation / revenue · 12 months12.34%Share-based compensation / revenue. Period ending 2026-06-30.

$171.45M ÷ $1.39B × 100 ≈ 12.34%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending321.37M USDResearch and Development Expense
Revenue1.39B USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation171.45M USDShare-based Payment Arrangement, Noncash Expense
Operating income-25.90M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30$321.37M$1.39B$171.45M$-25.90M(m)23.13%12.34%(m)(m)
2026-03-31$301.89M$1.31B$165.51M$-42.26M(m)23.01%12.61%(m)(m)
2025-12-31$291.21M$1.23B$162.03M$-67.76M(m)23.60%13.13%(m)(m)
2025-09-30$285.33M$1.15B$158.69M$-100.57M(m)24.73%13.75%(m)(m)
2025-06-30$268.44M$1.08B$149.81M$-103.01M(m)24.90%13.89%(m)(m)
2025-03-31$251.71M$1.01B$137.91M$-85.74M(m)24.99%13.69%(m)(m)
2024-12-31$238.46M$937.46M$135.21M$-84.08M(m)25.44%14.42%(m)(m)
2024-09-30$220.24M$868.92M$139.17M$-85.75M(m)25.35%16.02%(m)(m)
2024-06-30$305.92M$809.63M$407.59M$-374.68M(m)37.79%50.34%(m)(m)
2024-03-31$283.24M$752.00M$374.60M$-353.59M(m)37.66%49.81%(m)(m)
2023-12-31$262.18M$698.10M$340.80M$-330.62M$0.0037.56%48.82%(m)Reported
2023-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-12-31$104.08M$472.75M$6.80M$-55.04M$0.0022.02%1.44%(m)Reported
2022-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-12-31$65.60M$290.64M$35.25M$-79.23M$8.00K22.57%12.13%-9904.13×Reported

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.